BioSpace News Archive

LeMaitre, a provider of vascular devices, implants and services, reported Q1 2022 results, announced a $0.125/share quarterly dividend and provided guidance.

Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide business updates for the first quarter ended March 31, 2022, before the US markets open on Monday, May 9, 2022.

Dyadic International, Inc. announced that it will report its financial results for the first quarter 2022 and host a corporate update conference call on Thursday, May 12, 2022.

Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2022 first quarter financial results on Monday, May 9, 2022, before the market opens.

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), announced today the publication of “Noninvasive Genomic Characterization of Patients with Nonsclerotic and Superficially Sclerotic Chronic Cutaneous Graft-Versus-Host Disease Identified a Novel Gene Signature in Responders to Ruxolitinib Cream,” in Transplantation and Cellular Therapy.

Peak Bio Co., Ltd., a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory diseases, and Ignyte Acquisition Corp., a special purpose acquisition company, announced they have entered into a definitive business combination agreement.

All results are reported under International Financial Reporting Standards (“IFRS”) and in Canadian dollars, unless otherwise specified.

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, announced that it will report first quarter 2022 financial results after the U.S. financial markets close on Thursday, May 5, 2022.

Vektor Medical today announced positive results from its “Vektor vMap™ Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap™.

Apollo Medical Holdings, Inc. announced that it will release financial results for the first quarter ended March 31, 2022, after the close of the stock market on Thursday, May 5, 2022.